The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Auditor

4 Oct 2022 15:30

RNS Number : 7583B
Maven Income & Growth VCT PLC
04 October 2022
 

MAVEN INCOME AND GROWTH VCT PLC (Maven VCT), MAVEN INCOME AND GROWTH VCT 3 PLC (Maven VCT 3), MAVEN INCOME AND GROWTH VCT 4 PLC (Maven VCT 4), and MAVEN INCOME AND GROWTH VCT 5 PLC (Maven VCT 5); (each a Company and together the Companies) 

Change of Auditor

Following a formal tender process, the Companies are pleased to announce the appointment of Johnston Carmichael LLP (Johnston Carmichael) as its new Auditor with effect from 4 October 2022. Johnston Carmichael will conduct the audit of each Company's financial statements for their current financial years, which are to 30 November 2022 for Maven VCT 3 and Maven VCT 5; 31 December 2022 for Maven VCT 4; and 28 February 2023 for Maven VCT. The appointment of Johnston Carmichael as Auditor for each Company's subsequent financial year will be subject to approval by Shareholders at their next respective Annual General Meetings, all to be held in 2023.

In accordance with Section 519 of the Companies Act 2006, the Company's previous Auditor, Deloitte LLP (Deloitte), has deposited a statement with each of the Companies of the circumstances connected with them ceasing to hold office as Auditor of the Companies (the Statement). Each Statement confirms that Deloitte resigned as Auditor of the relevant Company because they considered that the fee was uneconomic, given the effort required to conduct the audit. Copies of the Statements will be sent to every person who is entitled to receive a copy of each Company's Annual Reports and Financial Statements.

The Boards of the Companies wish to take this opportunity to extend their appreciation and gratitude to Deloitte for the services rendered to the Companies during its respective periods of tenure.

Issued on behalf of the Companies

Maven Capital Partners UK LLP, Secretary

4 October 2022

Enquiries: 

Graeme Cullen, Maven Capital Partners UK LLP:

Tel: +44 (0) 141 206 0110

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPGBPUUPPGCC
Date   Source Headline
4th Oct 20221:35 pmRNSNet Asset Value(s)
26th Aug 202210:14 amRNSIssue of Equity
22nd Aug 20229:36 amRNSStatement re Dividend Investment Scheme
11th Aug 20224:47 pmRNSTransaction in Own Shares
25th Jul 20227:00 amRNSHalf-year Report
12th Jul 202212:40 pmRNSUnaudited Net Asset Value and Dividend Declaration
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
4th May 20229:28 amRNSIssue of Equity - Dividend Investment Scheme
3rd May 20225:07 pmRNSTransaction in Own Shares
28th Apr 20224:37 pmRNSStatement re Dividend Investment Scheme
27th Apr 202211:10 amRNSNet Asset Value(s)
26th Apr 20221:01 pmRNSResult of AGM
10th Mar 20224:57 pmRNSAnnual Financial Report
10th Mar 20227:00 amRNSRelated Party Transaction
23rd Feb 20223:57 pmRNSTransaction in Own Shares
17th Feb 20224:45 pmRNSTransaction in Own Shares
16th Feb 20223:56 pmRNSTransaction in Own Shares
9th Feb 20224:51 pmRNSTransaction in Own Shares
4th Feb 20224:26 pmRNSStatement re NAV and Dividend
26th Nov 202111:13 amRNSDirector/PDMR Shareholding
26th Nov 202111:11 amRNSDirector/PDMR Shareholding
26th Nov 202110:50 amRNSIssue of Equity
22nd Nov 202110:54 amRNSStatement re Dividend Investment Scheme
20th Oct 20211:00 pmRNSDividend Declaration
8th Oct 20214:03 pmRNSTransaction in Own Shares
6th Oct 202111:23 amRNSNet Asset Value(s)
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 20219:59 amRNSDirector/PDMR Shareholding
10th Sep 20219:57 amRNSDirector/PDMR Shareholding
10th Sep 20219:31 amRNSIssue of Equity
7th Sep 20213:09 pmRNSStatement re Dividend Investment Scheme
10th Aug 20214:31 pmRNSHalf-year Report
5th Aug 20219:17 amRNSStatement re NAV and Interim Dividend
7th May 20213:54 pmRNSTransaction in Own Shares
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:03 pmRNSIssue of Equity
5th May 202112:56 pmRNSTransaction in Own Shares
4th May 20214:01 pmRNSStatement re Dividend Investment Scheme
4th May 20213:54 pmRNSDirector/PDMR Shareholding
4th May 20213:25 pmRNSIssue of Equity
27th Apr 20211:46 pmRNSNet Asset Value(s)
27th Apr 20211:17 pmRNSResult of AGM
6th Apr 20217:00 amRNSIssue of Equity
1st Apr 202110:33 amRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
15th Mar 20213:37 pmRNSAnnual Financial Report
3rd Mar 20213:05 pmRNSHolding(s) in Company
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.